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Abstract
The purpose of this study was to review all articles published in two temporarily available radiation oncology journals
(Radiation Oncology Investigations, Journal of Radiosurgery) in order to evaluate their scientific impact. From several
potential measures of impact and relevance of research, we selected article citation rate because landmark or
practice-changing research is likely to be cited frequently. The citation database Scopus was used to analyse number of
citations. During the time period 1996-1999 the journal Radiation Oncology Investigations published 205 articles, which
achieved a median number of 6 citations (range 0-116). However, the most frequently cited article in the first 4 volumes
achieved only 23 citations. The Journal of Radiosurgery published only 31 articles, all in the year 1999, which achieved a
median number of 1 citation (range 0-11). No prospective randomized studies or phase I-II collaborative group trials
were published in these journals. Apparently, the Journal of Radiosurgery acquired relatively few manuscripts that were
interesting and important enough to impact clinical practice. Radiation Oncology Investigations’ citation pattern was
better and closer related to that reported in several previous studies focusing on the field of radiation oncology. The
vast majority of articles published in temporarily available radiation oncology journals had limited clinical impact and
achieved few citations. Highly influential research was unlikely to be submitted during the initial phase of establishing
new radiation oncology journals.
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Background
Scientifc publishing is an important task for radiation
oncologists pursuing an academic career (Holliday et al.
2014). Many of these physicians or physician-scientists
undergo yearly rating, and are more or less forced to
produce a certain number of publications or surrogate
achievements such as impact factor (Holliday et al. 2013).
Collaborative groups competing for research funding also
feel the pressure of succeeding with clinical trials and pub-
lishing their results in prestigious journals (Nieder 2012).
Many well-established journals with high impact factor
have low acceptance rates of submitted manuscripts. Con-
tinuous increases in number of submissions and competi-
tion for space result in a need for additional publication
channels. Publishing companies launching new journals
face the challenges of attracting a sufficient number of sci-
entifically sound manuscripts, achieving high visibility in
search engines, and achieving indexing in databases such
as PubMed. A rapidly increasing impact factor is also help-
ful for the continued success of new journals. During the
second half of the 1990s, when the field was dominated by
the “International Journal of Radiation Oncology, Biology
and Physics” and “Radiotherapy and Oncology”, two at-
tempts were made to establish additional specialty jour-
nals, “Radiation Oncology Investigations” and “Journal
of Radiosurgery”. However, these traditional print jour-
nals without page charges did not succeed and were
taken off the market after few volumes. We hypothe-
sized that failure was caused by insufficient number of
publications that were interesting and important enough
to attract readers and impact clinical practice, and that
this lack of appeal would be reflected by low number of
citations for most published studies. In order to evaluate
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this hypothesis, patterns of citation for these two journals
were analysed.
Materials and methods
A systematic search of the citation database Scopus
(Elsevier B.V., http://www.elsevier.com/online-tools/scopus)
by use of the function ‘document search’ was performed on
3rd of July 2014. All articles published in “Radiation Onco-
logy Investigations” and the “Journal of Radiosurgery” were
selected irrespective of subject area, document and article
type (review, clinical study, experimental study, case report
etc.). Then, these articles were ranked by number of cita-
tions (field ‘times cited’ in the Scopus citation database). As
requested during manuscript review, we also performed
comparisons to the “International Journal of Radiation
Oncology, Biology and Physics”. The respective Scopus
search was performed on 6th of February 2015.
Results
During the time period 1996-1999 “Radiation Oncology
Investigations” published 205 articles, which achieved a
median number of 6 citations (range 0-116). Figure 1
shows the distribution of citations. References (Seymour
& Mothersill 1997; Sheridan et al. 1997; Desai et al. 1998;
Schmidt-Ullrich et al. 1999; Smith & Haffty 1999; Johnson
et al. 1998; Monga et al. 1999; Stickle et al. 1999; Merrick
et al. 1998; Roach et al. 1997; Wazer et al. 1999; Joschko
et al. 1997; Chidel et al. 1999; Durand & Olive 1997;
Peschel et al. 1999; Norman et al. 1997; Kramer et al.
1998; Leborgne et al. 1997; Epperly et al. 1999; Chancy
et al. 1998; Prete et al. 1998; Fernandez-Vicioso et al.
1997; Kang & Suh 1999; Banasiak et al. 1999; Nathu et al.
1998; Haffty et al. 1997; Gieger et al. 1997) and Table 1 in-
clude the 25 most frequently cited articles (all had at least
30 citations and were published in volumes 5-7, most em-
anated from the USA). The most frequently cited article in
the first 4 volumes achieved 23 citations (Teicher et al.
1996). As also shown in Table 1, the median number of
authors was 5 (range 2-10). Both clinical, dosimetric and
radiobiological research as well as reviews achieved at least
30 citations. The most common topics were radiobiol-
ogy (n = 8) and prostate cancer (n = 6). Topics covered
all technological developments of that decade, e.g. brachy-
therapy, stereotactic radiotherapy and intensity-modulated
radiotherapy. No final results of randomized studies or
phase I-II collaborative group trials were published. The
most common type of research were retrospective clinical
studies (n = 10, Table 1). The median number of patients
in these studies was limited (40.5, range 3-123).
The “Journal of Radiosurgery” published 31 articles, all
in the year 1999, which achieved a median number of 1 cit-
ation (range 0-11, Figure 1). References (Garell et al. 1999;
Maire et al. 1999; Gibon et al. 1999; Solberg et al. 1999;
Sanghavi et al. 1999) include the 5 most frequently cited
articles (all had at least 5 citations and were published in
volume 2). Both clinical and physics research as well as re-
views achieved any citations. No randomized studies or
phase I-II collaborative group trials were published.
The “International Journal of Radiation Oncology,
Biology and Physics” published almost 2200 articles
during the time period 1996-1999. These achieved a
median number of 22 citations (range 0-1135). Overall,
9% of articles achieved at least 100 citations (p = 0.0002 in
Chi-Square test comparing the three journals).
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Figure 1 Patterns of citation of all articles published in Radiation Oncology Investigations (ROI) and the Journal of Radiosurgery (JRS).
Nieder et al. SpringerPlus  (2015) 4:93 Page 2 of 6
Table 1 The most frequently cited articles published in “Radiation Oncology Investigations” (in order of citation
frequency, references 4-30)
Short title Authors (number
of authors)
Country
of origin
Topic Design Comments
Mutations and genomic
instability
Seymour CB and
Mothersill C (2)
Ireland Radiobiology In vitro study
Radiosensitivity in squamous
cell cancer
Sheridan MT et al. (4) Ireland Radiobiology In vitro study
Morbidity following prostate
brachytherapy
Desai J et al. (5) USA Prostate cancer Retrospective
clinical study
117 patients
Accelerated repopulation Schmidt-Ullrich
RK et al. (8)
USA Radiobiology Review
Molecular markers in
head and neck cancer
Smith BD and Haffty
BG (2)
USA Head and neck
cancer
Review Review of prognostic factors
Bulky cervical
lymphadenopathy
Johnson CR et al. (4) USA Head and neck
cancer
Retrospective
clinical study
81 patients
Fatigue in patients with
prostate cancer
Monga U et al. (4) USA Prostate cancer Prospective
clinical study
36 patients, external beam irradiation
Prevention of esophagitis Stickle RL et al. (5) USA Radiobiology Mouse model plasmid/liposome delivery of the human
manganese superoxide dismutase transgene
Prostate brachytherapy Merrick GS et al. (4) USA Prostate cancer Dosimetric
evaluation
10 patients
Prostate volumes and
movement
Roach M 3rd et al. (3) USA Prostate cancer Dosimetric
evaluation
10 patients
Positive margins and local
recurrence
Wazer DE et al. (6) USA Breast cancer Retrospective
clinical study
105 patients
Radiation plus gemcitabine Joschko MA et al. (7) Australia Radiobiology Mouse model Squamous cell carcinoma
Single brain metastases Chidel MA et al. (5) USA Lung cancer Retrospective
clinical study
33 patients
Tirapazamine Durand RE and
Olive PL (2)
Canada Radiobiology Mouse model Physiologic and cytotoxic effects
Prostate brachytherapy Peschel RE et al.(4) USA Prostate cancer Retrospective
clinical study
123 patients
Canine brain tumors Norman A et al. (6) USA Brain tumors Retrospective
study
Irradiation in pet dogs
Radiosurgery vs. intensity-
modulated RT
Kramer BA et al. (5) USA Brain tumors Dosimetric
evaluation
Irregularly shaped targets
Biologically effective doses Leborgne F et al. (5) Uruguay Cervical cancer Radiobiology
data
Evaluation of clinical brachytherapy data
Overexpression of MnSOD Epperly MW et al. (6) USA Radiobiology In vitro study Hematopoietic progenitor cells
Phyllodes tumor of breast Chancy AW et al. (4) USA Phyllodes tumor Retrospective
clinical study
8 patients
Prostate brachytherapy Prete JJ et al. (5) USA Prostate cancer Dosimetric
evaluation
15 patients
Radiosurgery for single
brain metastases
Fernandez-Vicioso
E et al. (5)
USA Brain tumors Retrospective
clinical study
48 patients
Neurosarcoidosis Kang S and Suh
JH (2)
USA Neurosarcoidosis Retrospective
clinical study
3 patients
Cellular radiosensitivity Banasiak D et al.(5) Australia Radiobiology In vitro study Bladder cancer and ureteral cells
Merkel cell carcinoma Nathu RM et al. (3) USA Skin cancer Retrospective
clinical study
24 patients
Porfiromycin Haffty BG et al. (10) USA Head and neck
cancer
Phase I and III
data
Acute toxicity interim analysis of a phase III
study
Radiosurgery of melanoma
metastases
Gieger M et al. (6) USA Brain tumors Retrospective
clinical study
12 patients
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Discussion
The objective of this review was to identify pattern of
scientific publication in two radiation oncology journals
which were only temporarily available. While Radiation
Oncology Investigations covered the whole field of radi-
ation oncology, the Journal of Radiosurgery had a much
narrower focus. After arbitrary decisions about which
database to search (only those providing citation numbers
could be considered for the purpose of this review), we
performed a comprehensive evaluation of published re-
search and number of citations accumulated during more
than a decade after publication of the final journal volume.
These citation numbers can be considered mature because
previous analyses demonstrated that citation rate is
gradually increasing for the first years after publication,
followed by rapid decline (except for landmark random-
ized studies, which change clinical practice) (Stringer et al.
2010; Kondziolka 2011). Citation rate of published articles
was chosen to define the most important contributions.
Articles with high numbers of citations are likely those
that impressed other clinicians/scientists and had impact
on clinical practice or future developments in the field
(Shao et al. 2013). It should be noticed that searches in dif-
ferent databases will result in more or less variable citation
counts and that the present results therefore provide only
a snapshot. This has been illustrated, e.g., in a cohort study
of 328 articles published in JAMA, Lancet, or the New
England Journal of Medicine between October 1, 1999,
and March 31, 2000 (Kulkarni et al. 2009). Total citation
counts for each article up to June 2008 were retrieved
from Web of Science, Scopus, and Google Scholar. Google
Scholar and Scopus retrieved more citations per article
with a median of 160 and 149, respectively, than Web of
Science (median 122, p < 0.001 for both comparisons).
Importantly, Web of Science, Scopus and Google Scholar
produced quantitatively and qualitatively different citation
counts.
In a previous study of radiosurgery for various condi-
tions, 1.5% of all articles (time period 1951-2010) achieved
more than 100 citations (Kondziolka 2011). This figure
corresponds well to that of articles in Radiation Oncology
Investigations (3 out of 205, 1.5%), while the “International
Journal of Radiation Oncology, Biology and Physics”
achieved significantly higher proportions during the same
time interval (1996-1999; 9%). The Top 100 radiation on-
cology articles from the time period 1999-2001 achieved a
median of 208 citations (range 121-1149) (Nieder et al.
2013a), i.e. more than any of the publications reviewed
here. When comparing articles published during different
time periods, sources of bias must be acknowledged (vari-
able temporal patterns of citation, increasing use of online
databases in recent years, better access to published articles).
An analysis restricted to German radiation oncology
publications revealed that most citations per year since
publication were recorded for meta-analyses and random-
ized phase III trials (Nieder 2012). Lower figures were
recorded for review articles, non-phase III prospective
clinical trials, and retrospective clinical studies. Another
analysis demonstrated that pattern of publication of the
most influential radiation oncology studies was dominated
by only two scientific journals: the Journal of Clinical
Oncology and the International Journal of Radiation On-
cology Biology and Physics (Nieder et al. 2013a). Several
newly launched journals (first issue after 1999) managed
to attract highly cited articles (Lancet Oncology, Nature
Reviews Clinical Oncology or Nature Reviews Cancer,
which had rapidly increasing impact factors). Apparently,
despite controversy around impact factors and optimal
evaluation of research productivity and quality (Kanaan
et al. 2011; Durieux & Gevenois 2010), researchers find
it attractive and desirable to publish their most import-
ant radiation oncology related work in the top journals
of the field. The present findings are in line with these
considerations.
Highly cited work is unlikely to be published in the first
volumes of new journals. Prospective randomized trials and
non-randomized trials performed by influential collabora-
tive groups are prefentially submitted to well-established
journals. It has also been shown that five newly established
oncology journals, in this case open access publications
without print issues, all published less than 50 articles
in their first annual volume (Nieder et al. 2013b). First
after 4-5 years number of articles per volume increased
sharply. At that time, the two journals analysed here were
already taken off the market. During the time period in
question (1996-1999), no other new radiation oncology
journals entered the market. However, afterwards two
successful journals were established (in 2006 “Radiation
Oncology” (open access, no print issues); in 2011 “Practical
Radiation Oncology” (print issues, sister journal to the
“International Journal of Radiation Oncology, Biology and
Physics”)). Regarding “Radiation Oncology”, the annual
volumes 2006-2008 all consisted of less than 50 articles. In
2009, contents expanded to 71 articles, while the most
recent volume (2014) featured approximately 300. On
the one hand, one could hypothesize that open access
fees might prevent authors from submitting to journals
like “Radiation Oncology”. On the other hand, advantages
such as rapid publication and unlimited distribution and
access appear to outweigh financial considerations. Insti-
tutional membership or publication funds and waiver of
fees for authors from countries with limited resources
might also encourage researchers to publish in open ac-
cess journals.
Conclusions
Highly cited research typically appears in relatively few
well-established journals. The vast majority of articles
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published in temporarily available radiation oncology jour-
nals had limited clinical impact and achieved few citations,
especially those accepted in the initial phase of marketing.
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